Dexcom (DXCM) Gross Margin (2010 - 2026)
Dexcom (DXCM) posted quarterly Gross Margin of 63.44% for Q2 2026, up 391.0% year-over-year from 12.92% in Q2 2025, and up 0.77% quarter-over-quarter from 62.95% in Q1 2026.
Dexcom (DXCM) Gross Margin (2010 - 2026) Analysis & Trends
Dexcom (DXCM) has reported Gross Margin for 17 consecutive years, with 63.44% the latest figure, recorded in Q2 2026.
- In Q2 2026, Gross Margin rose 391.0% year-over-year to 63.44%; the TTM figure through Jun 2026 stood at 62.47% (up 371.0% YoY), while the FY2025 annual figure was 60.1%, down 36.0% from the prior year.
- Gross Margin grew to 63.44% in Q2 2026 per DXCM's latest filing, from 62.95% in the prior quarter.
- Across five years, Gross Margin topped out at 66.4% in Q4 2022 and bottomed at 56.85% in Q1 2025.
- Historically, Gross Margin has averaged 62.18% across 5 years, with a median of 62.82% in 2025.
- Annual changes were most pronounced in 2022 — Gross Margin sank 552 bps — and 2026, when it jumped 610 bps.
- Dexcom's Gross Margin stood at 66.4% in 2022, then fell by 4 bps to 63.47% in 2023, then decreased by 7 bps to 58.9% in 2024, then gained by 7 bps to 62.93% in 2025, then increased by 1 bps to 63.44% in 2026.
- Business Quant data shows DXCM's Gross Margin at 63.44% in Q2 2026, 62.95% in Q1 2026, and 62.93% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 57.71% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 68.27% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 65.35% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 70.71% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 77.46% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 63.44% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 41.17% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 47.38% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 45.84% |
| 10 | Zimmer Biomet Holdings | 19.04 Bn | 18.63 Bn | 1.54 Bn | 70.81% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 63.44% |
| Mar 31, 2026 | 62.95% |
| Dec 31, 2025 | 62.93% |
| Sep 30, 2025 | 60.48% |
| Jun 30, 2025 | 59.53% |
| Mar 31, 2025 | 56.85% |
| Dec 31, 2024 | 58.90% |
| Sep 30, 2024 | 59.73% |
| Jun 30, 2024 | 62.40% |
| Mar 31, 2024 | 61.01% |
| Dec 31, 2023 | 63.47% |
| Sep 30, 2023 | 63.93% |
| Jun 30, 2023 | 62.71% |
| Mar 31, 2023 | 62.39% |
| Dec 31, 2022 | 66.40% |
| Sep 30, 2022 | 64.22% |
| Jun 30, 2022 | 64.56% |
| Mar 31, 2022 | 63.31% |
| Dec 31, 2021 | 67.69% |
| Sep 30, 2021 | 68.73% |